Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
63.7M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$8.78B
-
Value change
-
+$116M
-
Put/Call ratio
-
2.72
-
Number of buys
-
113
-
Number of sells
-
-103
-
Price
-
$137.67
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2024
267 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2024.
Ascendis Pharma A/S - ADR (ASND) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.7M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.1M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (5.53M shares), Avoro Capital Advisors LLC (5.1M shares), FMR LLC (4.73M shares), Artisan Partners Limited Partnership (4.45M shares), JANUS HENDERSON GROUP PLC (4.38M shares), Capital International Investors (2.86M shares), T. Rowe Price Investment Management, Inc. (2.73M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.28M shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.87M shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.